生物降解材料聚乳酸的研究进展

介绍了可生物降解材料聚乳酸的合成、改性、应用以及聚乳酸生物降解性的研究进展,进行了较详细地综述和总结,并对聚乳酸的发展前景进行了展望。     

保加利亚乳杆菌微胶囊化工艺研究

目的制备保加利亚乳杆菌微胶囊,提高菌株的酸、热耐受性及降低菌体的分离成本。方法以保加利亚乳杆菌(Lactobacillus bulgaricus)为研究对象,海藻酸钠(SA)为壳材、CaCl2为固化剂,制备保加利亚乳杆菌微胶囊;包埋率、颗粒平均化程度、机械强度等为考核指标,研究保加利亚乳杆菌微胶囊化的工艺。结果当海藻酸钠浓度为0.75%、CaCl2浓度为3%、电压为600V、泵速为1.96mL/min、震动频率为80Hz时,微胶囊化包埋效果最佳,经固定化后的菌微胶囊保持了良好的保加利亚乳杆菌的活性,微囊化保加利亚乳杆菌经过2次连续发酵后的产酸量分别达到59.4g/L和55.8g/L。结论本研究为工业化生产乳酸提供了一条具有经济价值的途径。     

Production of flavour ketones in aqueous-organic two-phase systems by using free and microencapsulated fungal spores as biocatalysts

The formation of 2-alkanones by free and microencapsulated P. roquefortii spores in an aqueous-organic two-phase system was investigated by using substrates supplied as a solution in decane. It was shown that the spores remained catalytically active after entrapment within permeable polyamide microcapsules and readily catalyzed the formation of 2-pentanone, 2-heptanone, and 2-undecanone from short-chain alkyl esters of hexanoic, octanoic, and lauric acid, respectively, with the rate of reaction being markedly dependent on the type and concentration of the ester substrate used. In general, the optimal concentration of the esters in decane was found to be much higher than that of the respective fatty acid substrates and, in the case of alkyl dodecanoates, the biotransformation could be carried out efficiently even in the absence of added solvent. Further analysis revealed a significant difference in the reaction rates observed with free and microencapsulated spores at 0.5 but not at 3.0 M methyl dodecanoate, suggesting that at high substrate concentrations the biotransformation was no longer limited by mass transfer.     

海藻酸钙微囊对乳酸乳球菌在胃肠道环境中的保护作用

乳酸菌是机体内一类重要的益生菌,因其益生功能和安全性,在食品行业和医疗保健领域有着广泛的应用,此外将乳酸菌作为口服疫苗载体或药物传递载体也是目前的研究热点之一。乳酸菌到达肠道的活菌数是影响其功能有效性的一个重要因素,需考虑为其提供一定的防护来抵御胃酸等恶劣环境。通过化学法制备能稳定表达Gfp的乳酸乳球菌海藻酸钙微囊,以Gfp作为活菌标记,检测了海藻酸钙微囊对乳酸乳球菌的保护作用。体外实验结果显示,酸处理30、60、90、120 min后,海藻酸钙微囊包裹使乳酸乳球菌的存活率分别提高了1 370、525、235和105倍。动物体内实验也表明,在灌胃2 h后,海藻酸钙微囊包裹使乳酸乳球菌在肠道内的活菌数增加90多倍。上述结果说明海藻酸钙微囊对乳酸乳球菌在胃肠道环境中具有明显的保护作用,为今后乳酸乳球菌口服制剂的研究及开发提供重要的参考依据。     

L-ascorbic acid microencapsulated with polyacylglycerol monostearate for milk fortification

Efficiency was examined of microencapsulating L-ascorbic acid by polyglycerol monostearate (PGMS), and changes in the chemical and sensorial aspects of L-ascorbic acid and/or iron-fortified milk during storage were evaluated. The selected core materials were ferric ammonium sulfate and L-ascorbic acid. The highest efficiency (94.2%) of microencapsulation was found with the ratio of 5:1 as the coating to core material. The release of ascorbic acid from the microcapsules increased sharply from 1.6 to 6.7% up to 5 d of storage. The TBA value was the lowest in the milk sample with added encapsulated iron and unencapsulated L-ascorbic acid up to 5 d of storage in comparison with the other treated samples. A sensory analysis showed that most aspects were not significantly different between the control and fortified samples encapsulated with ascorbic acid after 5 d of storage. The results indicate that L-ascorbic acid microencapsulated with PGMS can be applied to fortify milk and acceptable milk products can be prepared with microencapsulated L-ascorbic acid and iron.     

Growth of recombinant fibroblasts in alginate microcapsules

To develop a novel strategy of nonautologous somatic gene therapy, we now demonstrate the feasibility of culturing genetically modified fibroblasts within an immunoprotective environment and the optimal conditions required for their continued survival in vitro. When mouse Ltk(-) fibroblasts transfected with the human growth hormone gene were enclosed within permselective microcapsules fabricated from alginate-polylysine-alginate, they continued to secrete human growth hormone at the same rates as the nonencapsulated cells. They also continued to proliferate in vitro for at least 1 month even though their viability gradually declined to about 50%. The viability can be improved by controlling for (a) temperature during encapsulation, (b) duration of treatment with polylysine, (c) duration of liquefying the core alginate with sodium citrate, and (d) cell density at the time of encapsulation. The best conditions leading to improved survival and maximum proliferation of cells within the microcapsules were obtained by encapsulating the cells at 4 to 10 degrees C instead of room temperature, coating the microspheres with polylysine for 6 to 10 min instead of 20 min, liquefying the core alginate by treating with citrate for 20 min instead of 6 to 10 min, and using a concentration of 2 x 10(6) cells/mL of alginate for encapsulation. Under such conditions, normally adherent and genetically engineered mouse fibroblasts survived and proliferated optimally within the microcapsule environment. The encapsulated fibroblasts maintained their level of transgene expression while recombinant gene products such as human growth hormone could diffuse through the microcapsule membrane without impediment. The demonstration that genetically modified fibroblasts can survive and continue to deliver recombinant gene products from within these microcapsules and the optimization for their maximal viability and growth within microcapsules should increase the potential for success in using such microencapsulated recombinant cells for somatic gene therapy. (c) 1994 John Wiley & Sons, Inc.     

Enzymatically activated microencapsulated liposomes can provide pulsatile drug release

A system for the delayed or pulsed release of biologically active substances was achieved by encapsulating liposomes containing the substance of interest inside microcapsules. The microcapsules retain the liposomes but allow controlled diffusion of the active substance when it is released from the liposomes. Furthermore, by coating the liposomes with phospholipase A2 (an enzyme that removes an acyl group from the 2 position of phospholipids) before placing them within the microcapsule, a pulsatile release pattern was achieved both in vitro and in vivo. The time of onset of the pulse as well as the release rate can be controlled by the amount of phospholipase A2, the molecular weight of the poly(L-lysine) that is used to coat the microencapsulated liposomes, and the composition of the phospholipid bilayer membrane. Even at 37 degrees C the system would protect a model enzyme (horseradish peroxidase). When not placed inside the microencapsulated liposomes, the enzyme lost its activity in solution at 37 degrees C in a few days, whereas it retained 40% of the initial activity after 30 days of incubation at 37 degrees C inside the microencapsulated liposomes.     

微囊化新生大鼠卵巢组织体外及异体移植

为探讨海藻酸钠-聚左赖氨酸-海藻酸钠(APA)微囊化新生大鼠卵巢组织用于治疗实验性卵巢功能丧失大鼠的可行性,应用高压静电法,用海藻酸钠-聚左赖氨酸-海藻酸钠(APA)生物膜包裹新生大鼠卵巢组织,体外培养微囊,用免疫化学分析法检测雌二醇(E2)、孕酮(P)分泌情况,透射电镜观察卵巢组织形态,并将微囊移植到去势大鼠(切除双侧卵巢的雌性大鼠)腹腔中,检测大鼠血清中雌、孕激素变化情况,同时用阴道涂片观察大鼠动情周期恢复情况,并在不同时间回收观察微囊。结果显示在相同条件下制得的微囊粒径均匀、表面光滑;体外培养条件下持续分泌E2、P;卵巢组织中颗粒细胞发育成为粒性黄体细胞;大鼠腹腔移植微囊后无异常,E2、P水平上升,动情周期未恢复;回收的微囊大部分形态完整。提示用高压静电法制备的APA微囊化新生大鼠卵巢组织能持续稳定释放E2、P,明显改善大鼠卵巢功能,在大鼠体内有良好的生物相容性。     

Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates.

Purified reovirus serotype 1, encapsulated in biodegradable aqueous microcapsules, was found to bypass maternal antibody passively transferred by suckling to neonates. Genetically identical, immunocompetent F1 scid/+ mice were generated by the reciprocal crosses of C.B17 scid/scid and normal congenic +/+ adult mice. The immunocompetent +/+ dams were either orally infected with reovirus prior to mating or not. Thus, these immunocompetent F1 pups developed either in the absence or in presence of passively transferred maternal immunity. The F1 mice were orally immunized on day 10 with either live virus, microencapsulated reovirus, or empty microcapsules plus live virus. The immune responses were assessed in the neonatal gut-associated lymphoid tissues (GALT). Examination of reovirus specific immunoglobulin A in the serum and GALT, taken on days 7, 14, and 21 postimmunization, clearly demonstrated that microencapsulated reovirus could bypass the normal effect of maternal antibodies, passively acquired by suckling, to inhibit active priming of neonates by oral route. These observations seem relevant to the development of efficacious oral vaccines that also allow passive, protective immunity via suckled maternal antibodies while permitting active oral immunization of neonates.     

聚乳酸(PLA)生物降解的研究进展

聚乳酸(Polylactic Acid,PLA)是一种新兴的,由可再生资源--乳酸聚合而成的高分子聚酯.因为其具有优良的物理化学性能、生物相容性及生物可降解性,且对环境及人体无毒害作用,而被认为是一种最具潜力的绿色生物塑料.作为环境友好材料,聚乳酸日益受到人们的重视.基于可循环利用的考虑,其生物降解的研究也成为当前研究的一个重要方面.本文综述了PLA生物降解领域的相关进展,包括降解的微生物学、相关酶学及分子生物学,系统阐述了PLA可能的生物降解机制.并对生物系统处理PLA废弃物的可行性进行了探讨.     

Microencapsulation of bovine liver arginase: Characterization and in vivo evaluation of its effect on the growth of the L1210 murine leukaemia

Bovine liver arginase (EC 3.5.3.1) was encapsulated within nylon membrane microcapsules by the process of interfacial polymerization. The effect of microencapsulation on the properties of arginase was investigated. The K_m, pH optimum and temperature stability at 37°C of arginase, were not significantly altered. The microencapsulated enzyme was much less stable at temperatures between 50 and 70°C than the free enzyme. Native arginase was inactivated by exposure to proteolytic enzymes, whereas microencapsulated arginase was much more resistant to proteolysis. A preliminary investigation of the effectiveness of the microencapsulated enzyme against the L1210 murine leukaemia in vivo has been made.     

Comparison of microcapsule density with various apple tissues and formulations of oriental fruit moth (Lepidoptera: Tortricidae) sprayable pheromone

The density of microcapsules was compared on 'Golden Delicious' mature and immature foliage, fruit, and 1-yr-old limbs after dip treatments with Phase III oriental fruit moth, Grapholita molesta (Busck), microencapsulated pheromone. Microcapsules were counted with a dissecting microscope at 50x magnification after apple tissues were treated with a two-step dye staining process to increase the visibility of the microcapsules. The number of Phase III microcapsules on 1-yr limbs treated with a field concentration was two- to threefold greater than the number of microcapsules on similarly treated fruit or foliage. Phase I, III, and V OFM MEC and Checkmate OFM-F formulations of microencapsulated pheromone also were compared to determine their abundance on mature apple foliage. The Phase V OFM MEC formulation had the highest density of microcapsules when mature foliage was treated at the field rate. The Phase I treatment had the greatest difference between upper and lower leaf surfaces with 18-fold greater microcapsule density on the upper surface. On mature apple leaves treated with Phase III MEC, the number of microcapsules/cm2 was two- to threefold greater on fields of view without the mid-vein than those that included the mid-vein. The cuticle structure and abundance of trichomes are two factors that may have contributed to differences in microcapsule density among plant tissue types, top and bottom leaf surfaces, and fields of view with and without the mid-vein.     

Microencapsulation of canine sperm and its preservation at 4 °C

The objective of this study was to develop a preservation method for canine sperm using microencapsulation. Pooled ejaculates from three beagles (Canis familiaris) were extended in egg yolk Tris extender and were encapsulated in gel (alginate only) or polycation (poly-l-lysine membrane bound) microcapsules at 0.75% and 1.0% alginate concentration. In Experiment 1, characteristics of microcapsule and microencapsulated sperm were evaluated during chilling storage for 48 h. Gel microcapsules at 0.75% alginate concentration had a teardrop-like structure with fragility, whereas those at 1.0% alginate had a solid spherical structure. In all groups, diameter of the microcapsules increased with duration of storage (P < 0.05). Alginate concentration did not affect the sperm recovery rate from microcapsules. Total average recovery rate of sperm from polycation microcapsules was lower than that of gel microcapsules (P < 0.05). Progressive motility of polycation microencapsulated sperm and unencapsulated sperm (control) was higher than that of the gel microencapsulated sperm, both at 0.75% and 1.0% alginate concentration (P < 0.05), although viability of sperm was similar among the three groups. In Experiment 2, to evaluate the sperm longevity after chilling storage, sperm were microencapsulated in polycation microcapsules at 1.0% alginate concentration, stored at 4 °C for 0, 1, 4, and 7 d, and then cultured at 38.5 °C for 0, 6, and 24 h. Progressive motility and viability of microencapsulated sperm were higher than those of unencapsulated spermatozoa at 0 to 24 h of culture after 4 and 7 d of chilling storage (P < 0.05). In conclusion, polycation microencapsulation at 1.0% alginate concentration can be successfully applied for chilling storage of canine sperm by maintaining motility and viability for up to 7 d.     

以聚γ-谷氨酸为材质研制微胶囊的工艺

微胶囊制剂能够利用壁材将囊芯物质包裹起来,减少外界环境的不良因素对其造成的影响,但存在产品残效期和速效性的矛盾、成本过高等问题。聚γ-谷氨酸具有成膜性,可生物降解。本文通过自制的枯草芽胞杆菌聚γ-谷氨酸,对开发聚γ-谷氨酸微胶囊的工艺展开研究。对壁材浓度、搅拌转速、反应温度、聚γ-谷氨酸∶明胶质量比、菌悬液体积和甲醛的用量进行优化,建立了聚γ-谷氨酸微胶囊制备工艺,微胶囊对枯草芽胞杆菌的包埋率达到94.2%。同时考察了微胶囊制剂对热、紫外线和极端pH的抗逆性,结果表明聚γ-谷氨酸-明胶微胶囊能赋予微生物细胞更强的抗紫外能力和耐热性。在极端pH条件下热处理,聚γ-谷氨酸-明胶微胶囊剂中枯草芽胞杆菌的存活率也显著提高。     

Incorporation of proteins into polyelectrolyte microcapsules by coprecipitation and adsorption

Microcapsules composed of synthetic (sodium polystyrene sulfonate and polyallylamine hydrochloride) and biodegradable polyelectrolytes (dextran sulfate and polyarginine hydrochloride) deposited on carbonate microparticles have been obtained. The ultrastructural organization of biodegradable microcapsules has been studied by transmission electron microscopy. The shell of biodegradable microcapsules is well formed even after the deposition of six polyelectrolyte layers and has an average thickness of 44 ± 3.0 nm; their inner polyelectrolyte matrix is less branched than that of synthetic microcapsules. By using spectroscopy, the efficiency of the encapsulation of FITC-labeled BSA by adsorption depending on the number of PE layers in the capsule has been estimated. It has been shown that the maximum amount of the protein is incorporated into capsules comprising six and seven polyelectrolyte layers (4 and 2 pg/capsule, respectively). It has been concluded that the adsorption of proteins into preformed polyelectrolyte capsules enables one to avoid protein losses that occur with the method in which biomineral cores obtained by coprecipitation are used for encapsulation.     

Cryopreservation of microencapsulated canine sperm

The objective was to develop a method for cryopreserving microencapsulated canine sperm. Pooled ejaculates from three beagle dogs were extended in egg yolk tris extender and encapsulated using alginate and poly-L-lysine at room temperature. The microcapsules were cooled at 4 °C, immersed in pre-cooled extender (equivalent in volume to the microcapsules) to reach final concentration of 7% (v/v) glycerol and 0.75% (v/v) Equex STM paste, and equilibrated for 5, 30 and 60 min at 4 °C. Thereafter, microcapsules were loaded into 0.5 mL plastic straws and frozen in liquid nitrogen. In Experiment 1, characteristics of microencapsulated canine sperm were evaluated after glycerol addition at 4 °C. Glycerol exposure for 5, 30 and 60 min did not significantly affect progressive motility, viability, or acrosomal integrity of microencapsulated sperm compared with pre-cooled unencapsulated sperm (control). In Experiment 2, characteristics of frozen-thawed canine microencapsulated sperm were evaluated at 0, 3, 6, and 9 h of culture at 38.5 °C. Pre-freeze glycerol exposure for 5, 30, and 60 min at 4 °C did not influence post-thaw quality in unencapsulated sperm. Post-thaw motility and acrosomal integrity of microencapsulated sperm decreased more than those of unencapsulated sperm (P < 0.05) following glycerol exposure for 5 min. However, motility, viability and acrosomal integrity of microencapsulated sperm after 30 and 60 min glycerol exposure were higher than unencapsulated sperm cultured for 6 or 9 h (P < 0.05). In conclusion, since microencapsulated canine sperm were successfully cryopreserved, this could be a viable alternative to convention sperm cryopreservation in this species.     

Entrapment of dispersed pancreatic islet cells in CultiSpher-S macroporous gelatin microcarriers: Preparation, in vitro characterization, and microencapsulation.

Immunoprotection of pancreatic islets for successful allo- or xenotransplantation without chronic immunosuppression is an attractive, but still elusive, approach for curing type 1 diabetes. It was recently shown that, even in the absence of fibrotic overgrowth, other factors, mainly insufficient nutrition to the core of the islets, represent a major barrier for long-term survival of intraperitoneal microencapsulated islet grafts. The use of dispersed cells might contribute to solve this problem due to the conceivably easier nutritional support to the cells. In the present study, purified bovine islets, prepared by collagenase digestion and density gradient purification, and dispersed bovine islet cells, obtained by trypsin and DNAsi (viability > 90%), were entrapped into either 2% (w/v) sodium alginate (commonly used for encapsulation purposes) or (dispersed islet cells only) macroporous gelatin microcarriers (CulthiSpher-S, commonly used for the production of biologicals by animal cells). Insulin release studies in response to glucose were performed within 1 week and after 1 month from preparation of the varying systems and showed no capability of dispersed bovine islet cells within sodium alginate microcapsules to sense glucose concentration changes. On the contrary, bovine islet cells entrapped in CulthiSpher-S microcarriers showed maintained capacity of increasing insulin secretion upon enhanced glucose concentration challenge. In this case, insulin release was approximately 60% of that from intact bovine islets within sodium alginate microcapsules. MTT and hematoxylineosin staining of islet cell-containing microcarriers showed the presence of viable and metabolically active cells throughout the study period. This encouraging functional data prompted us to test whether the microcarriers could be immunoisolated for potential use in transplantation. The microcarriers were embedded within 3% sodium alginate, which was then covered with a poly-L-lysine layer and a final outer alginate layer. Maintained insulin secretion function of this system was observed, which raises the possibility of using microencapsulated CulthiSpher-S microcarriers, containing dispersed pancreatic islet cells, in experimental transplantation studies.     

Improving mechanical stability and density distribution of hepatocyte microcapsules by fibrin clot and gold nano-particles

Bio-artificial livers (BAL) with microencapsulated hepatocytes have the typical limitations in maintaining hepatocyte functions, mechanical stability and uniform perfusion in packed or fluidized-bed bioreactors. We have previously developed microcapsules with enhanced hepatocyte functions. Here we have introduced a fibrin network inside microcapsules by (1) mixing collagen and fibrinogen with the encapsulated hepatocytes to support the cells; (2) submerging the microcapsules into a thrombin solution to induce the formation of an insoluble fibrin network inside the microcapsules. Fracture analysis on the microcapsules revealed significant improvement in mechanical stability. We have also introduced different amounts of gold nano-particles into microcapsules to achieve different densities for uniform bioreactor perfusion. These gold nano-particles also improved the mechanical stability of the microcapsules. Both the fibrin network and gold nano-particles exhibited the additional benefits of enhancing certain bio-functions of the encapsulated hepatocytes. The applications of these improved microcapsules in the development of bio-artificial livers are discussed.     

Water-stable all-biodegradable microparticles in nanofibers by electrospinning of aqueous dispersions for biotechnical plant protection

Pheromone eluting oligolactide (OLA) microcapsules immobilized in electrospun biodegradable polyester nanofibers were obtained by electrospinning of aqueous dispersions of the microcapsules. OLA was prepared by conventional melt polycondensation of lactic acid. Following the protocol of the solvent displacement method, OLA was dissolved in acetone and mixed with Brij S20 and the pheromone of the European grape vine moth, Lobesia Botrana, (E,Z)-7,9-dodecadien-l-yl acetate (DA). Up to 32 wt % of this mixture could be dispersed in water with colloidal stability of several weeks without any sedimentation. Without DA as well as OLA, no stable dispersions of OLA in water were obtained. Replacement of DA by classical hydrophobes typically used for miniemulsions did not yield stable dispersions, but the addition of octyl acetate, which shows structural similarity to DA, yielded stable dispersions in water up to 10 wt %. Dispersions of OLA/DA were successfully electrospun in combination with an aqueous dispersion of a biodegradable block copolyester resulting in water-stable nanofibers containing OLA/DA microcapsules. Release of DA from microcapsules and fibers was retarded in comparison with non-encapsulated DA, as shown by model studies.     

Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria

Phenylalanine ammonia-lyase immobilized within semipermeable microcapsules has an assayed enzyme activity which is 20% +/- 4% of the enzyme in free solution. The Km for the immobilized enzyme remained the same as that of the free enzyme. The pH optimum also remained unchanged at pH 8.5 +/- 1.0. At the lower pH range, enzyme activity is higher for the immobilized enzyme. Daily oral administration of microencapsulated phenylalanine ammonia-lyase to phenylketonuric rats decreased the systemic phenylalanine level by 35 +/- 8% in 2 days (P less than 0.05) and by 75 +/- 8% in 7 days (P less than 0.001).